• Title/Summary/Keyword: osteopathic

Search Result 22, Processing Time 0.016 seconds

Shoulder Joint Range of Motion Change Research Frozen Shoulder Therapy KTO (Korea Traditional Osteopathy) (KTO(Korea Traditional Osteopathy)를 이용한 동결견 치료 시 견관절 가동범위 변화 연구)

  • Byun, Sangjoon;Kang, Cheolho;Choi, Guirack;Hong, Seong Gyun
    • Journal of the Korean Society of Radiology
    • /
    • v.7 no.3
    • /
    • pp.205-211
    • /
    • 2013
  • This study is for patients who are diagnosed with Frozen Shoulder, Korean traditional osteopath (KTO) was applied. The reduction of pain in patients with significant pain relief who studied how to increase the range of motion of the shoulder joint in order to additionally confirm. Consists of a total of 14 subjects, divided into two groups of seven experimental groups and seven control groups was studied. KTO seven patients was performed a total of 10 times seven patients was not performed. Look at each item, if the range of motion of the shoulder joint, The group looked at the changes in the operation value when applying the KTO Flexion (7.33), Extension (10.00), Abduction (8.76), Adduction (9.05), external rotation (8.10), internal rotation (10.00) was changed. The group looked at the changes in the operation value when did not apply the KTO Flexion (7.33), Extension (10.00), Abduction (8.76), Adduction (9.05), external rotation (8.10), internal rotation (10.00) was changed. That you can bring an increase in range of motion of the shoulder Frozen Shoulder Korean traditional osteopathic treatment to patients.

Long-Term Survival of Women with Locally Advanced Breast Cancer with ≥10 Involved Lymph Nodes at Diagnosis

  • Zeichner, Simon Blechman;Cavalcante, Ludimila;Suciu, Gabriel Pius;Ruiz, Ana Lourdes;Hirzel, Alicia;Krill-Jackson, Elisa
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.8
    • /
    • pp.3435-3441
    • /
    • 2014
  • Background: Axillary lymph node status at diagnosis remains the strongest predictor of long-term survival in breast cancer. Patients with more than ten axillary lymph nodes at diagnosis have a poor long-term survival. In this single institutional study, we set out to evaluate the prognosis of this high-risk group in the era of multimodality therapy. Materials and Methods: In this retrospective study, we looked at all breast cancer patients with greater than ten axillary lymph nodes diagnosed at Mount Sinai Medical Center (MSMC) from January 1st 1990 to December 31st 2007 (n=161). In the univariate analysis, descriptive frequencies, median survival, and 5- and 10-year survival rates were estimated for common prognostic factors. A multivariate prognostic analysis for time-to-event data, using the extended Cox regression model was carried out. Results: With a median and mean follow-up of 70 and 89.9 months, respectively, the overall median survival was estimated to be 99 months. The five-year disease-free survival (DFS) was 59.3% and the ten-year DFS was 37.9%, whereas the five- and ten-year overall survival (OS) was 66.6% and 43.9%, respectively. Multivariate analysis revealed a significant improvement in DFS among black patients compared to whites (p=0.05), improved DFS and OS among young patients (ages 21-45) compared to elderly patients (age greater than 70) (p=0.00176, p=0.0034, respectively), and improved DFS and OS among patients whose tumors were ER positive (p=0.049, p=0.0034). Conclusions: In this single institution study of patients with greater than 10 positive axillary nodes, black patients had a significantly improved DFS compared with white patients. Young age and ER tumor positivity was associated with improved outcomes. Using multivariate analysis, there were no other variables associated with statistically significant improvements in DFS or OS including date of diagnosis. Further work is needed to improve breast cancer survival in this subgroup of patients.